Psilocybin helps reduce depression in clinicians amid COVID-19 crisis
Coronavirus
University of Washington School of Medicine/UW Medicine Dec 5 2024 Psilocybin-assisted psychotherapy resulted in significant reductions in depression among clinicians who provided front-line COVID-19 care in 2020 and 2021. These reductions were measurably greater than those experienced by the cohort of clinicians who received a placebo instead. Findings from this double-blind, randomized clinical trial are to be published in JAMA Network Open at 8 a.m. PST Thursday, Dec. 5.. For doctors and
din zilele anterioare